EPSN financial statements and SEC filings
EPSN annual income statement
| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
|---|
| 2025-12-31 | $51.59M | -$10.52M | -$5.80M | 10-K |
| 2024-12-31 | $31.52M | $3.42M | $1.93M | 10-K |
| 2023-12-31 | $30.73M | $5.42M | $6.95M | 10-K |
| 2022-12-31 | $69.96M | $46.97M | $35.35M | 10-K |
| 2021-12-31 | $42.40M | $20.61M | $11.63M | 10-K |
| 2020-12-31 | $24.43M | -$977.70K | $875.17K | 10-K/A |
EPSN annual balance sheet
| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
|---|
| 2025-12-31 | $228.24M | $103.51M | $124.73M | 10-Q |
| 2024-12-31 | $120.45M | $23.73M | $96.73M | 10-K |
| 2023-12-31 | $124.04M | $23.43M | $100.61M | 10-K |
| 2022-12-31 | $123.86M | $19.62M | $104.25M | 10-K |
| 2021-12-31 | $99.46M | $20.20M | $79.26M | 10-K |
| 2020-12-31 | $86.68M | $17.66M | $69.02M | 10-K/A |
EPSN annual cash flow
| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
|---|
| 2025-12-31 | $20.62M | – | $43.68M | 10-K |
| 2024-12-31 | $16.83M | – | -$7.32M | 10-K |
| 2023-12-31 | $18.19M | – | -$11.73M | 10-K |
| 2022-12-31 | $38.01M | – | -$11.35M | 10-K |
| 2021-12-31 | $20.01M | – | -$2.34M | 10-K |
| 2020-12-31 | $14.82M | – | -$9.08M | 10-K/A |